Stockholders' Equity (Details) - Schedule of the changes in outstanding warrants |
9 Months Ended |
|---|---|
|
Sep. 30, 2021
$ / shares
shares
| |
| Schedule of the changes in outstanding warrants [Abstract] | |
| Number of Shares, Outstanding and vested, Beginning balance | shares | 2,670,633 |
| Weighted Average Exercise Price Per Share, Outstanding and vested, Beginning balance | $ / shares | $ 9.11 |
| Number of Shares, Granted | shares | 930,000 |
| Weighted Average Exercise Price Per Share, Granted | $ / shares | $ 32.21 |
| Number of Shares, Exercised | shares | (356,385) |
| Weighted Average Exercise Price Per Share, Exercised | $ / shares | $ 5.94 |
| Number of Shares, Outstanding and vested, Ending balance | shares | 3,244,248 |
| Weighted Average Exercise Price Per Share, Outstanding and vested, Ending balance | $ / shares | $ 16.08 |
| Number of Shares, Warrants Vested | shares | 2,829,873 |
| Weighted Average Exercise Price Per Share, Warrants Vested | $ / shares | $ 8.13 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their warrant into shares. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Exercise Price Per Share, Granted. No definition available.
|
| X | ||||||||||
- Definition Number of Shares, Warrants exercisable. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock warrant plan No definition available.
|
| X | ||||||||||
- Definition Weighted Average Exercise Price Per Share, Vested. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|